Keyword: AliveCor

AliveCor has secured an FDA clearance for its personal device offering six leads, providing more detailed views into heartbeats and arrhythmias.

AliveCor has secured two additional FDA clearances for its personal electrocardiogram, allowing it to detect bradycardia and tachycardia arrhythmias.

The Mayo Clinic and AliveCor showed how AI can identify increased risks of arrhythmias and sudden cardiac death despite a normal rhythm on an EKG.

Pairing the algorithm with AliveCor’s smartphone and Apple Watch-based ECGs could enable the remote, noninvasive monitoring of potassium levels.

The regulatory nod covers AliveCor’s KardiaBand, a device that clips onto Apple’s smartwatch and performs EKG readings.

Check out the rest of Thursday's news of note.

Mayo Clinic and AliveCor are developing a low-cost, portable screening tool for long QT, which can cause sudden cardiac death.

AliveCor is launching a new platform to help physicians manage reports from its smartphone ECG recorder.

In a collaboration with Mayo Clinic, AliveCor will apply its smartphone electrocardiogram device and machine learning algorithms to tease out new physiological indicators of heart health as well as general health.

Smartphone ECG maker AliveCor is partnering with Omron Healthcare to integrate blood pressure data into its mobile app, creating the first tool of its kind to help patients “paint a more complete picture of heart health.”